Media
Bloomberg: Intrivo CEO on CareStart™ EUA approvals
August 12, 2020
Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)
